OLD Second National Bank of Aurora boosted its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 0.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,684 shares of the company’s stock after purchasing an additional 81 shares during the quarter. OLD Second National Bank of Aurora’s holdings in Zoetis were worth $2,283,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its position in Zoetis by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 40,749,571 shares of the company’s stock valued at $6,895,235,000 after buying an additional 414,605 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Zoetis by 4.0% in the second quarter. Bank of New York Mellon Corp now owns 4,687,902 shares of the company’s stock valued at $812,695,000 after acquiring an additional 178,303 shares in the last quarter. Capital Research Global Investors boosted its holdings in Zoetis by 2.3% in the 1st quarter. Capital Research Global Investors now owns 4,050,681 shares of the company’s stock valued at $685,416,000 after purchasing an additional 90,330 shares in the last quarter. Clearbridge Investments LLC raised its stake in shares of Zoetis by 5.8% during the 2nd quarter. Clearbridge Investments LLC now owns 3,044,384 shares of the company’s stock worth $527,774,000 after buying an additional 166,517 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its stake in shares of Zoetis by 17.3% in the third quarter. Principal Financial Group Inc. now owns 2,377,403 shares of the company’s stock valued at $464,497,000 after buying an additional 351,372 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.
Analysts Set New Price Targets
ZTS has been the topic of several research analyst reports. BTIG Research boosted their price target on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Stifel Nicolaus raised their target price on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. Argus raised Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. JPMorgan Chase & Co. boosted their price target on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Piper Sandler increased their price objective on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Ten equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Zoetis has a consensus rating of “Buy” and a consensus target price of $221.44.
Zoetis Stock Down 1.2 %
NYSE ZTS opened at $173.95 on Wednesday. The company has a market capitalization of $78.48 billion, a P/E ratio of 32.70, a PEG ratio of 2.70 and a beta of 0.90. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The company’s 50 day simple moving average is $187.81 and its 200 day simple moving average is $180.04.
Zoetis (NYSE:ZTS – Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The business had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.36 earnings per share. Equities research analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.
Zoetis Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be issued a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a dividend yield of 0.99%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s dividend payout ratio is currently 32.52%.
About Zoetis
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
See Also
- Five stocks we like better than Zoetis
- What is a Stock Market Index and How Do You Use Them?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Insider Trading – What You Need to Know
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
- How to Evaluate a Stock Before Buying
- Is Palantir’s AI Edge Enough to Justify Its Price?
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.